| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |